Related references
Note: Only part of the references are listed.Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer
Afsana Sheikh et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Amir R. Afshari et al.
SEMINARS IN CANCER BIOLOGY (2022)
Nanoparticle delivery systems to combat drug resistance in ovarian cancer
Emily M. Miller et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)
Potential of nanoparticulate based delivery systems for effective management of alopecia
Priya Mishra et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance
Yanhua Zhang et al.
BIOMATERIALS (2021)
Nanocarrier-delivered small interfering RNA for chemoresistant ovarian cancer therapy
Mingyuan Zou et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
Melayshia McFadden et al.
CANCERS (2021)
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
Rahul Chadar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics
Vanshikha Singh et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2021)
hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/ wortmannin
Somayyeh Ghareghomi et al.
LIFE SCIENCES (2021)
Biocompatible AlEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer
Jun Wu et al.
THERANOSTICS (2021)
Immune checkpoint inhibitors: a promising anticancer therapy
Sima Singh et al.
DRUG DISCOVERY TODAY (2020)
Tuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface Chemistry
Santiago Correa et al.
ACS NANO (2020)
siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery
Chunbai He et al.
ACTA BIOMATERIALIA (2020)
Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo
Petro Zhupanyn et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment
Min Ju Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman et al.
MATERIALS & DESIGN (2020)
Polymeric Carriers for Delivery Systems in the Treatment of Chronic Periodontal Disease
Magdalena Zieba et al.
POLYMERS (2020)
Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
Antonella Pietragalla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Nano-scaled materials may induce severe neurotoxicity upon chronic exposure to brain tissues: A critical appraisal and recent updates on predisposing factors, underlying mechanism, and future prospects
Zahid Hussain et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
Ujjwal Joshi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer
Shin Nishio et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics
Fabiana de Sousa Cunha et al.
JOURNAL OF DRUG TARGETING (2019)
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance
Jiayi Pan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes
Bruna Corradetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors
Isabelle M. S. Degors et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Hereditary ovarian cancers: state of the art
Angela Toss et al.
MINERVA MEDICA (2019)
Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging
Prashant Kesharwani et al.
PROGRESS IN MATERIALS SCIENCE (2019)
Engineering the Binding Kinetics of Synthetic Polymer Nanoparticles for siRNA Delivery
Hiroyuki Koide et al.
BIOMACROMOLECULES (2019)
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Shahin Aghamiri et al.
NANOMEDICINE (2019)
Ovarian cancer: Current status and strategies for improving therapeutic outcomes
Ashwin Chandra et al.
CANCER MEDICINE (2019)
siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer
Christopher Halbur et al.
SLAS TECHNOLOGY (2019)
Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy
Fan Zhuo et al.
CARBOHYDRATE POLYMERS (2018)
Polymer-Based Drug Delivery Systems for Cancer
Ru Wen et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2018)
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee Kim et al.
DRUG DELIVERY (2018)
Administration of antioxidants in cancer: debate of the decade
Rajneet Kaur Khurana et al.
DRUG DISCOVERY TODAY (2018)
Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery
Prashant Kesharwani et al.
DRUG DISCOVERY TODAY (2018)
Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration
Jinlei Dong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood-brain barrier
Mohammed A. S. Abourehab et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity
Ashay Jain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
siRNA in ovarian cancer - Delivery strategies and targets for therapy
Dirk van den Brand et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Blocking Sternness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery
Jing Ma et al.
MOLECULAR THERAPY (2018)
PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
Chitra Risnayanti et al.
SCIENTIFIC REPORTS (2018)
Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation
R. Ferrari et al.
NANOSCALE (2018)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Strategies for improving drug delivery: nanocarriers and microenvironmental priming
Ayesha Khalid et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
Robert Cornelison et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Carina I. C. Crucho et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models
Cai M. Roberts et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
A facile strategy for fine-tuning the stability and drug release of stimuli-responsive cross-linked micellar nanoparticles towards precision drug delivery
Kai Xiao et al.
NANOSCALE (2017)
Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy
Muhammad Wahab Amjad et al.
PROGRESS IN POLYMER SCIENCE (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
Emma C. Fields et al.
FRONTIERS IN ONCOLOGY (2017)
Front-line therapy of advanced epithelial ovarian cancer: standard treatment
C. Marth et al.
ANNALS OF ONCOLOGY (2017)
Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers
Duy Luong et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Revisiting the value of competition assays in folate receptor-mediated drug delivery
Steven K. Jones et al.
BIOMATERIALS (2017)
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
Soo Hyeon Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
Yu-Hung Huang et al.
CANCER RESEARCH (2016)
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Nazila Kamaly et al.
CHEMICAL REVIEWS (2016)
PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery
Iliyas Khan et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2016)
Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy
Anish Babu et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2016)
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer
Canan Schumann et al.
MOLECULAR PHARMACEUTICS (2016)
Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors
Adeel Masood Butt et al.
MOLECULAR PHARMACEUTICS (2016)
Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation
Bin Yang et al.
CURRENT DRUG DELIVERY (2016)
Highly efficient Gab2 siRNA delivery to ovarian cancer cells mediated by chitosan-polyethyleneimine nanoparticles
Lei Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Prediction of drug-ABC-transporter interaction - Recent advances and future challenges
Floriane Montanari et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Chemically Modified Dendritic Starch: A Novel Nanomaterial for siRNA Delivery
Sarah A. Engelberth et al.
BIOCONJUGATE CHEMISTRY (2015)
Dendrimer generational nomenclature: the need to harmonize
Prashant Kesharwani et al.
DRUG DISCOVERY TODAY (2015)
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
Prashant Kesharwani et al.
DRUG DISCOVERY TODAY (2015)
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications
Randy Chi Fai Cheung et al.
MARINE DRUGS (2015)
PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
Prashant Kesharwani et al.
MATERIALS TODAY (2015)
In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Code livery of Doxorubicin and siRNA to Colorectal Adenocarcinomas
Muhammad Wahab Amjad et al.
MOLECULAR PHARMACEUTICS (2015)
Smart Polymeric Nanoparticles for Cancer Gene Delivery
Guimei Lin et al.
MOLECULAR PHARMACEUTICS (2015)
ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression
Canan Schumann et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Design considerations for nanotherapeutics in oncology
Triantafyllos Stylianopoulos et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
Pei Yun Teo et al.
ADVANCED HEALTHCARE MATERIALS (2015)
The importance of nanoparticle shape in cancer drug delivery
Nghia P. Truong et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
Xiaoqian Yang et al.
PHARMACEUTICAL RESEARCH (2015)
Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations
Prashant Kesharwani et al.
PHARMACEUTICAL RESEARCH (2015)
New perspectives on targeted therapy in ovarian cancer
Jermaine I. G. Coward et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2015)
Recent Advances in Nanoparticle-Mediated siRNA Delivery
John-Michael Williford et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16 (2014)
The heterogeneity of ovarian cancer
I. Meinhold-Heerlein et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
siRNA nanotherapeutics: a Trojan horse approach against HIV
Vijay Mishra et al.
DRUG DISCOVERY TODAY (2014)
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy
Tony Shing Chau Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Combination of Dendrimer-Nanovector-Mediated Small Interfering RNA Delivery to Target Akt with the Clinical Anticancer Drug Paclitaxel for Effective and Potent Anticancer Activity in Treating Ovarian Cancer
Shashwati Kala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer
Kshipra M. Gharpure et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells
Anish Babu et al.
MOLECULAR PHARMACEUTICS (2014)
Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector
Prashant Kesharwani et al.
NANOMEDICINE (2014)
Copolymer of poly(ethylene glycol) and poly((L)-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery
Jingguo Li et al.
NANOSCALE (2014)
RNA interference: concept to reality in crop improvement
Satyajit Saurabh et al.
PLANTA (2014)
NANOTECHNOLOGY IN MEDICINE: CONCEPTS AND CONCERNS
Juliana Cancino et al.
QUIMICA NOVA (2014)
MicroRNAs: Novel mediators of resistance to microtubule-targeting agents
Arun Kanakkanthara et al.
CANCER TREATMENT REVIEWS (2013)
Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
Vatsal Shah et al.
CLINICAL CANCER RESEARCH (2013)
Chitosan-based siRNA delivery systems
Heloise Ragelle et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers
Shrikant Thakur et al.
JOURNAL OF NANOPARTICLE RESEARCH (2013)
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Jiehua Zhou et al.
PHARMACEUTICALS (2013)
Pegylated Phospholipid Micelles Induce Endoplasmic Reticulum-Dependent Apoptosis of Cancer Cells but not Normal Cells
Jing Wang et al.
ACS NANO (2012)
Polymer-related off-target effects in non-viral siRNA delivery
Olivia M. Merkel et al.
BIOMATERIALS (2011)
Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Polymers in Small-Interfering RNA Delivery
Kaushik Singha et al.
NUCLEIC ACID THERAPEUTICS (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
Didier Astruc et al.
CHEMICAL REVIEWS (2010)
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Hee Dong Han et al.
CLINICAL CANCER RESEARCH (2010)
Dendrimer toxicity: Let's meet the challenge
Keerti Jain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Breaking down the barriers: siRNA delivery and endosome escape
Monika Dominska et al.
JOURNAL OF CELL SCIENCE (2010)
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
David A. Scheinberg et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells
Sunita Yadav et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Dendrimers as versatile platform in drug delivery applications
Sonke Svenson
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Advances of Cancer Therapy by Nanotechnology
Xu Wang et al.
CANCER RESEARCH AND TREATMENT (2009)
Polymeric Nanocarriers for siRNA Delivery: Challenges and Future Prospects
Dongmei Cun et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
Marina A. Dobrovolskaia et al.
MOLECULAR PHARMACEUTICS (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
Diagnosis and management of epithelial ovarian cancer
Snehal Bhoola et al.
OBSTETRICS AND GYNECOLOGY (2006)
A computational study of off-target effects of RNA interference
S Qiu et al.
NUCLEIC ACIDS RESEARCH (2005)
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
YL Chiu et al.
CHEMISTRY & BIOLOGY (2004)
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles:: implications for drug and gene delivery
J Panyam et al.
FASEB JOURNAL (2002)
Gene expression - RNA interference in adult mice
AP McCaffrey et al.
NATURE (2002)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Share Paper
